Long-term stroke prevention: We can do better
- PMID: 28739846
- PMCID: PMC5524575
- DOI: 10.1503/cmaj.170410
Long-term stroke prevention: We can do better
Conflict of interest statement
Competing interests: Michael Hill reports personal fees from Merck, non-financial support from Hoffmann-La Roche Canada Ltd., and grants from Covidien (Medtronic Minimally Invasive Therapies), Boehringer Ingelheim, Medtronic, NoNO Inc. and Stryker Inc., outside the submitted work. In addition, he has a patent pending for systems and methods for assisting in decision-making and triaging for acute stroke patients to the US Patent Office, number 62/086,077. He owns stock in Calgary Scientific Inc., a company that focuses on medical imaging software; is a director of the Canadian Neurological Sciences Federation, a not-for-profit group; and has received grant support from Alberta Innovates: Health Solutions, the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada and the National Institutes of Neurological Disorders and Stroke.
Comment on
-
Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack.CMAJ. 2017 Jul 24;189(29):E954-E961. doi: 10.1503/cmaj.161142. CMAJ. 2017. PMID: 28739847 Free PMC article.
Similar articles
-
Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1378-82. doi: 10.1016/j.jstrokecerebrovasdis.2015.02.023. Epub 2015 Mar 21. J Stroke Cerebrovasc Dis. 2015. PMID: 25804570
-
Practice variation in long-term secondary stroke prevention in The Netherlands.J Stroke Cerebrovasc Dis. 2015 Mar;24(3):566-72. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.031. Epub 2014 Dec 24. J Stroke Cerebrovasc Dis. 2015. PMID: 25543189
-
A systematic review of the benefits of mindfulness-based interventions following transient ischemic attack and stroke.Int J Stroke. 2013 Aug;8(6):465-74. doi: 10.1111/ijs.12135. Int J Stroke. 2013. PMID: 23879751 Review.
-
2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.Int J Stroke. 2017 Apr;12(3):302-320. doi: 10.1177/1747493017694391. Epub 2017 Mar 6. Int J Stroke. 2017. PMID: 28381199
-
Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.Cerebrovasc Dis. 2015;39(1):13-22. doi: 10.1159/000369778. Epub 2014 Dec 24. Cerebrovasc Dis. 2015. PMID: 25547900 Review.
Cited by
-
Evaluating Feasibility of a Secondary Stroke Prevention Program.Healthcare (Basel). 2023 Oct 2;11(19):2673. doi: 10.3390/healthcare11192673. Healthcare (Basel). 2023. PMID: 37830710 Free PMC article.
-
Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes?Int J Mol Sci. 2022 Jun 20;23(12):6840. doi: 10.3390/ijms23126840. Int J Mol Sci. 2022. PMID: 35743317 Free PMC article. Review.
-
Residual poststroke disability is another opportunity to reduce long-term morbidity and mortality.CMAJ. 2017 Sep 5;189(35):E1120. doi: 10.1503/cmaj.733356. CMAJ. 2017. PMID: 28874436 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical